ively with decrease in laughing and crying relative to environmental and interpersonal changes. There was a gradual and progressive loss of head control as well as progressive feeding difficulty.
There are four siblings. Both parents and the first girl born to the family are healthy. The second girl showed a 'central nervous system disorder'5 from birth, associated with measles encephalitis at the age of 2 years and at the present time is institutionalized. A third child, another girl, died at the age of 6 months from infantile subacute necrotizing encephalopathy. Postmortem examination revealed pathology similar to this case. It is the fourth girl who is being reported here. Pregnancies and deliveries of all four children were uneventful.
On admission, weight, height, and head circumference were 'significantly lower than normal'. Lethargy and little or no spontaneous movements were noted; however, the infant responded to light and auditory stimuli. Temperature was normal and there were no signs of neck rigidity or palpable abnormalities of the fontanelle. There was poor head control as well as poor grasp, rooting, and sucking reflexes and the Moro reflex was present and complete. Generalized muscle hypotonicity with brisk and symmetrical deep tendon reflexes were noted. LABORATORY STUDIES Electroencephalogram showed diffuse slowing more marked on the left side. Electrocardiogram, electromyogram, and radiographs of the chest and skull were normal. In normal children, the serotonin level (Hazra, Benson, and Sandler, 1965; Mitchell, and Cass, 1959) and the urinary excretion of 5-hydroxyindoleacetic acid (Serra, 1958; Rappallini and Murtagh, 1962) approach adult values between 6 weeks and 4 months of age.
The complete absence of urinary 5-hydroxyindoleacetic acid (adult normal value 2 to 9 mg/24 hr) suggested a possible abnormality in the amine metabolism in this patient.
Since the common denominator of this disorder is a necrotizing process in the brain-stem, it was decided to study the biogenic amines which play a decisive role in the maintenance of integrity of the extrapyramidal motor system in the brain. Any other biochemical studies conducted were consequential and explorative in nature and were carried out to delineate further the abnormalities found.
When a lack of 5-HIAA was discovered in the randomly collected urine, an attempt was made to study this metabolite more carefully. Therefore, two 24-hour urine samples were collected from the patient and a child of similar age and weight, who was hospitalized for a routine non-neurological condition, served as her control. The urine was frozen at -20°C, without addition of any preservative, immediately after it was voided. The negligible concentration of 5-HIAA in the 24-hour urine sample confirmed the previous findings of the clinical laboratory.
Since the enzymes which synthesize serotonin, dopamine, and gamma-amino butyric acid are B6 dependent (Holtz and Palm, 1964) , it was decided to examine the two systems extensively. At necropsy, a portion of the basal ganglia was removed for histopathological examination as well as for the estimation of the concentration of the amines and determination of the activities of certain key enzyme systems. The basal ganglia of two children who died from bacterial endocarditis and Wilm's tumour respectively served as control. The necropsy material, as well as histological examination of the brain tissue, revealed no detectable pathology in the latter children. Because of our previous knowledge that the patient's sister was affected with ISNE as well as the fact that brain amine concentration will decrease upon storage, the brain was removed within 30 minutes after death.
MATERIALS AND METHODS
Urinary 4-pyridoxic acid, xanthurenic acid, taurine, dopamine, and 5-hydroxyindoleacetic acid were determined according to the methods of Reddy, Reynolds, and Price (1958); Satoh and Price (1958) ; Hope (1957) ; Carlsson and Waldeck (1958); and Udenfriend, Weissbach, and Brodie (1958) respectively. The brain dopamine, noradrenaline, and serotonin were determined according to the method of Fleming, Clark, Fenster, and Towne (1965) , while the concentration of tryptamine was determined utilizing the method of Eccleston, Ashcroft, Crawford, and Loose (1966) . The activity of brain glutamic acid decarboxylase and pyridoxal phosphokinase were estimated according to the methods of Lowe, Robins, and Eyerman (1958), and McCormick, Gregory, and Snell (1961) respectively. The concentration of the amines and the activity of the enzymes were calculated on the basis of dry brain weight.
RESULTS
The biochemical abnormalities which were found in the urine as well as in the basal ganglia are summarized in Tables I and II respectively. There occurred an increase in the 24-hour excretion of 4-pyridoxic acid, as well as xanthurenic acid, while the concentration of taurine became depressed. Among the biogenic amine metabolites, the concentration of 5-hydroxyindoleacetic acid was almost undetectable, while a copious quantity of dopamine was discovered in the urine. Among the biogenic amines and enzymes measured in the basal ganglia, the concentrations of dopamine, noradrenaline, and serotonin and the activity of glumatic acid (Carlsson and Hillarp, 1962; Anden, Roos, and Werdinius, 1963) (Fig. 1) . In this patient the concentration of dopamine and noradrenaline in the basal ganglia were extremely low (Table II) . These low concentrations of the two amines could be caused by the depressed activity of dopa decarboxylase (which is a PLPdependent enzyme) resulting in inadequate formation of dopamine and of course, indirectly, noradrenaline. Although the basal ganglia contained very little dopamine, the urinary excretion of dopamine was high. These inconsistencies are very difficult to explain. Assuming that the low concentration of dopamine in the basal ganglia resulted from a depression in the activity of dopa decarboxylase, then why were similar enzymes not inhibited in the peripheral systems ? The findings can be explained only if one postulates that the activity of tyrosine hydroxylase and/or dopa decarboxylase in the brain and monoamine oxidase in the peripheral tissues were selectively inhibited (Fig. 1) . Because of an insufficient amount of experimental evidence, further description of this complex mechanism will not be undertaken.
The serotonin content of the basal ganglia was quantitatively negligible. This low concentration of serotonin in the brain is, however, in keeping with the extremely low excretion of 5-hydroxyindoleacetic acid in the urine (Table I) .
The existing serotonin in the body is formed from decarboxylation of 5-hydroxytryptophan by the aid of a PLP-dependent 5-hydroxytryptophan decarboxylase (Lovenberg et al., 1962) . The 5-hydroxytryptophan is produced by direct hydroxylation of tryptophan under the catalytic action of tryptophan hydroxylase. Tryptophan can also be directly decarboxylated, by tryptophan decarboxylase, to yield tryptamine (Werle and Mennicken, 1937) . Serotonin and tryptamine are oxidatively deaminated to yield 5-hydroxyindoleacetic acid which is excreted in concentrations of 2 to 9 mg/24 hr, and indoleacetic acid which is excreted in cons HTP decarboxylase* centrations of 5 to 18 mg/24 hr (Jackson and Chandler, 1939; and Weissbach, King, Sjoerdsma, and Udenfriend, 1959) (Fig. 2) . Although the concentration of serotonin in the basal ganglia is approximately 0 5 ,ug/g wet brain tissue, the concentration of tryptamine is negligible, since it is very rapidly oxidized to indoleacetic acid which is excreted in the urine. It is rather interesting that in this patient, in the absence of serotonin, the concentration of tryptamine became elevated (Table  II) with a far more complicated cause and aetiology. However, it is unlikely that the degenerative processes in the brain-stem would have been arrested, even if one had the capability of biochemically correcting the reported B6 and amine abnormalities. Furthermore, it is conceivable that these multiple enzymatic blockades, as reported in this paper and other studies (Greenhouse and Schneck 1968; Namiki, 1965; and Worsley et al., 1965) , are the results of non-specific action of a substance or substances elaborated by the disease, capable of creating a massive breakdown in decarboxylating mechanisms everywhere. The evidence presented in this report indicates that the inhibition in decarboxylating systems might be due to impairment in catalytic utilization of vitamin B6 derivatives. SUMMARY This paper reports the biochemical abnormalities found in the basal ganglia and the urine of a child with subacute necrotizing encephalopathy. The urinary levels of 4-pyridoxic acid, xanthurenic acid, and dopamine were elevated, whereas the levels of taurine and 5-hydroxyindoleacetic acid were depressed. The basal ganglia levels of dopamine, noradrenaline, serotonin, and the activity of the glutamic acid decarboxylase were depressed, whereas the level of tryptamine and the activity of pyridoxal kinase were elevated. These data are interpreted to indicate that in this child there occurred an impairment in utilization of vitamin B6 and in amino acid decarboxylating systems. 
